From: Management strategies for acute cholecystitis in late pregnancy: a multicenter retrospective study
Group A (n = 11) | Group B (n = 29) | Group C (n = 62) | |
---|---|---|---|
Age (years) | 29.47 ± 5.16 | 29.12 ± 3.16 | 28.92 ± 7.44 |
Gestational cycle | 35.26 ± 1.22 | 34.75 ± 2.54 | 35.45 ± 1.94 |
Symptoms and signs | |||
Right upper abdominal pain n (%) | 8 (72.72%) | 20 (68.96%) | 44 (70.97%) |
Fever n (%) | 2 (18.18%) | 6 (20.69%) | 1 (1.61%) |
Murphy positive n (%) | 6 (54.55%) | 17 (58.62%) | 3 (4.83%) |
Laboratory tests | |||
WBC (*109/L) | 16.54 ± 5.18 | 15.24 ± 3.18 | 11.77 ± 2.89 |
ALT (IU/L) | 90.26 ± 4.33 | 86.12 ± 5.42 | 56.88 ± 2.89 |
AST (IU/L) | 87.46 ± 7.52 | 88.33 ± 6.21 | 55.10 ± 1.99 |
Total bilirubin (umol/L) | 15.86 ± 2.17 | 15.22 ± 1.97 | 15.16 ± 2.66 |
Serum amylase | 42 ± 3.56 | 42 ± 4.55 | 43 ± 4.00 |
Ultrasound examination | |||
Gallbladder size (mean, cm×cm) | 10.33 × 4.37 | 9.95 × 5.76 | 6.89 × 3.15 |
Gallbladder wall thickness (mm) | 5.12 ± 0.33 | 4.85 ± 1.25 | 4.43 ± 2.25 |
Grade n(I/II/III) | 1/7/3 | 1/25/3 | 51/10/1 |
Length of hospitalization (days) | 4.02 ± 1.02 | 12.53 ± 2.21 | 11.22 ± 2.09 |
Readmission rate n (%) | 1 (9.09%) | 7 (24.14%) | 36 (58.06%) |
Preterm birth rate n (%) | 1 (9.09%) | 1 (3.45%) | 8 (12.90%) |